News & Events

Allison Siegenfeld, a postdoctoral trainee at Harvard Medical School, is studying a hallmark of cancer — the dysregulation of messenger RNA levels — to better understand how treatments can target this mechanism of action.

Dr. Lisa Volpatti of Northwestern University is creating a novel drug delivery system that treats inflammation by taking advantage of the body’s natural systems.

Yu-Hsiang Chen, a postdoctoral trainee at the University of Texas MD Anderson Cancer Center, is using single-cell technology to study the cancer cells that remain after stem cell transplant to treat blood cancer.

In this PhRMA Foundation webinar, learn about the importance of patient engagement in value assessment and health outcomes research and how applicants for PhF awards can demonstrate their commitment to patient-centered research.

Do you have questions about the PhRMA Foundation’s grants and fellowships? Join our team for an informational webinar and Q&A session about our 2026 research funding opportunities.

In this webinar, we’ll share an overview of Pfizer’s postdoc program and how to apply, and current Pfizer fellows will discuss their experiences and answer questions.

The PhRMA Foundation announced the appointment to its Board of Directors of Dr. Fiona H. Marshall, PhD, President of Biomedical Research at Novartis, and Dr. Patrizia Cavazzoni, MD, Chief Medical Officer and Executive Vice President at Pfizer.

The PhRMA Foundation announced the appointment to its Board of Directors of Dr. John C. Reed, MD, PhD, Executive Vice President of Innovative Medicine R&D at Johnson & Johnson (J&J), and Dr. Donatello Crocetta, MD, MBA, Chief Medical Officer and Head of Medical Communities at UCB.

The PhRMA Foundation awarded five early-career researchers with 2025 fellowships and grants in value assessment and health outcomes research.